Cargando…
Ganaxolone: A New Treatment for Neonatal Seizures
Neonatal seizures are amongst the most common neurologic conditions managed by a neonatal care service. Seizures can exacerbate existing brain injury, induce “de novo” injury, and are associated with neurodevelopmental disabilities in post-neonatal life. In this mini-review, we present evidence in s...
Autores principales: | Yawno, Tamara, Miller, Suzie L., Bennet, Laura, Wong, Flora, Hirst, Jonathan J., Fahey, Michael, Walker, David W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5572234/ https://www.ncbi.nlm.nih.gov/pubmed/28878622 http://dx.doi.org/10.3389/fncel.2017.00246 |
Ejemplares similares
-
Ganaxolone versus Phenobarbital for Neonatal Seizure Management
por: Miller, Suzanne L., et al.
Publicado: (2022) -
Ganaxolone: A New Treatment for CDKL5 Deficiency Disorder
por: Vossler, David G.
Publicado: (2022) -
Ganaxolone improves behavioral deficits in a mouse model of post-traumatic stress disorder
por: Pinna, Graziano, et al.
Publicado: (2014) -
The Beneficial Effects of Melatonin Administration Following Hypoxia-Ischemia in Preterm Fetal Sheep
por: Yawno, Tamara, et al.
Publicado: (2017) -
A randomized double-blind, placebo-controlled trial of ganaxolone in children and adolescents with fragile X syndrome
por: Ligsay, Andrew, et al.
Publicado: (2017)